Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Healios KK Ord Shs HLOSF

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.


PINL:HLOSF - Post by User

Post by sweenbyon Oct 11, 2010 10:22pm
277 Views
Post# 17552485

Very busy buying

Very busy buying

Pinetree Capital Ltd. (PNP)

As of October 10th, 2010
Filing Date Transaction Date Insider Name Ownership Type Securities Nature of transaction # or value acquired or disposed of Unit Price
Oct 08/10 Oct 01/10 Inwentash, Sheldon Direct Ownership Common Shares 10 - Acquisition in the public market 27,600 $1.896
Oct 08/10 Sep 30/10 Inwentash, Sheldon Direct Ownership Common Shares 10 - Acquisition in the public market 18,500 $1.976
Oct 08/10 Sep 30/10 Inwentash, Sheldon Direct Ownership Common Shares 10 - Acquisition in the public market 3,800 $1.980
Oct 08/10 Sep 30/10 Inwentash, Sheldon Direct Ownership Common Shares 10 - Acquisition in the public market 77,700 $1.937
Oct 08/10 Sep 30/10 Inwentash, Sheldon Direct Ownership Common Shares 10 - Acquisition in the public market 100,000 $1.973
Oct 08/10 Sep 29/10 Inwentash, Sheldon Direct Ownership Common Shares 10 - Acquisition in the public market 150,000 $1.865
Oct 07/10 Sep 27/10 Inwentash, Sheldon Direct Ownership Common Shares 10 - Acquisition in the public market 50,000 $1.760
Oct 04/10 Sep 24/10 Inwentash, Sheldon Direct Ownership Common Shares 10 - Acquisition in the public market 125,000 $1.739
Oct 04/10 Sep 24/10 Inwentash, Sheldon Direct Ownership Common Shares 10 - Acquisition in the public market 7,700 $1.730
Oct 04/10 Sep 24/10 Inwentash, Sheldon Direct Ownership Common Shares 10 - Acquisition in the public market 52,300 $1.721
- Amended Filing
<< Previous
Bullboard Posts
Next >>